- Home
- FRD vs MBOT Comparison
FRD vs MBOT Comparison
Compare FRD & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRD | MBOT |
|---|---|---|
| Founded | 1965 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.3M | 145.7M |
| IPO Year | 1995 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FRD | MBOT |
|---|---|---|
| Price | $16.74 | $2.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 22.7K | ★ 1.8M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | N/A | ★ 30.48 |
| EPS | ★ 1.46 | N/A |
| Revenue | ★ $121,157,278.00 | $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4,200.00 |
| P/E Ratio | $11.66 | ★ N/A |
| Revenue Growth | ★ 55.82 | N/A |
| 52 Week Low | $12.24 | $1.35 |
| 52 Week High | $24.37 | $4.62 |
Technical Indicators
Market Signals| Indicator | FRD | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 31.39 | 63.23 |
| Support Level | $16.58 | $2.34 |
| Resistance Level | $17.18 | $3.13 |
| Average True Range (ATR) | 0.74 | 0.18 |
| MACD | -0.15 | 0.03 |
| Stochastic Oscillator | 12.12 | 76.55 |
Price Performance
Historical ComparisonAbout FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.